PULMONX CORPORATION Increase (Decrease) in Accounts Payable
PULMONX CORPORATION (LUNG) reported Increase (Decrease) in Accounts Payable of $773.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-04
- PULMONX CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.20M, a 43.79% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$430.00K, a 185.15% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.50M.
- PULMONX CORPORATION increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $121.00K, a 91.02% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts payable for fiscal 2025 was $270.00K, a 88.15% decline from fiscal 2024.
- PULMONX CORPORATION increase (decrease) in accounts payable for fiscal 2024 was $2.28M.
- PULMONX CORPORATION increase (decrease) in accounts payable for fiscal 2023 was -$345.00K, a 239.68% decline from fiscal 2022.
- PULMONX CORPORATION increase (decrease) in accounts payable for fiscal 2022 was $247.00K, a 183.91% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $773.00K 10-Q · filed 2026-08-04 | -$1.72M derived: sum of 3 quarters · filed 2026-08-04 | -$1.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$430.00K 10-Q · filed 2026-05-04 | -$2.93M derived: sum of 2 quarters · filed 2026-05-04 | -$2.81M derived: sum of 3 quarters · filed 2026-05-04 | -$665.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$2.38M derived: sum of 2 quarters · filed 2026-03-10 | -$235.00K derived: sum of 3 quarters · filed 2026-08-04 | $270.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.26M derived: sum of 2 quarters · filed 2026-08-04 | $2.77M 10-Q · filed 2025-11-12 | $2.07M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.65M 10-Q · filed 2026-08-04 | $1.95M derived: sum of 3 quarters · filed 2026-08-04 | $3.29M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $505.00K 10-Q · filed 2026-05-04 | -$195.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.15M derived: sum of 3 quarters · filed 2026-05-04 | $1.15M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $648.00K derived: sum of 2 quarters · filed 2026-03-10 | $643.00K derived: sum of 3 quarters · filed 2026-03-10 | $2.28M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.34M derived: sum of 2 quarters · filed 2025-11-12 | $2.98M 10-Q · filed 2025-11-12 | $1.28M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.63M 10-Q · filed 2025-08-01 | -$68.00K derived: sum of 3 quarters · filed 2025-08-01 | $935.00K derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $1.64M 10-Q · filed 2025-05-02 | -$63.00K derived: sum of 2 quarters · filed 2025-05-02 | $940.00K derived: sum of 3 quarters · filed 2025-05-02 | $422.00K derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$695.00K derived: sum of 2 quarters · filed 2025-02-25 | -$1.21M derived: sum of 3 quarters · filed 2025-02-25 | -$345.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $485.00K derived: sum of 2 quarters · filed 2024-11-01 | $1.35M 10-Q · filed 2024-11-01 | $523.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $350.00K 10-Q · filed 2024-08-02 | -$480.00K derived: sum of 3 quarters · filed 2024-08-02 | -$465.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $868.00K 10-Q · filed 2024-05-03 | $38.00K derived: sum of 2 quarters · filed 2024-05-03 | $53.00K derived: sum of 3 quarters · filed 2024-05-03 | -$146.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$830.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$815.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.01M derived: sum of 3 quarters · filed 2024-02-27 | $247.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$184.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.08M 10-Q · filed 2023-11-03 | -$1.74M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.06M 10-Q · filed 2023-08-04 | -$1.75M derived: sum of 3 quarters · filed 2023-08-04 | $856.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-08 | -$1.56M derived: sum of 2 quarters · filed 2023-05-08 | $1.05M derived: sum of 3 quarters · filed 2023-05-08 | $1.05M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$206.00K derived: sum of 2 quarters · filed 2023-03-01 | -$215.00K derived: sum of 3 quarters · filed 2023-03-01 | $87.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.60M derived: sum of 2 quarters · filed 2022-11-08 | $2.90M 10-Q · filed 2022-11-08 | $3.66M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $293.00K 10-Q · filed 2022-08-08 | $1.05M derived: sum of 3 quarters · filed 2022-08-08 | $1.65M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $302.00K 10-Q · filed 2022-05-09 | $1.06M derived: sum of 2 quarters · filed 2022-05-09 | $1.66M derived: sum of 3 quarters · filed 2022-05-09 | $1.06M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.36M derived: sum of 2 quarters · filed 2022-03-01 | $755.00K derived: sum of 3 quarters · filed 2022-03-01 | $592.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $603.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$3.00K derived: sum of 2 quarters · filed 2021-11-09 | -$166.00K 10-Q · filed 2021-11-09 | $209.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$606.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$769.00K 10-Q · filed 2021-08-10 | -$394.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$163.00K 10-Q · filed 2021-05-12 | $212.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $524.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $149.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | -$648.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |